1. 242 Baseline characteristics of patients with lupus nephritis requiring rituximab therapy: results from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR). (12th April 2019) Authors: Collinson, Sophie; Parker, Ben; McCarthy, Eoghan M; Sutton, Emily; Jayne, David; Griffiths, Bridget; Isenberg, David A; Rahman, Anisur; Gordon, Caroline; D'Cruz, David P; Hewins, Peter; Rhodes, Benjamin; Lanyon, Peter; Vital, Edward M; Yee, Chee-Seng; Edwards, Christopher J; Teh, Lee-Suan; Akil, ... Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register. (5th December 2017) Authors: McCarthy, Eoghan M; Sutton, Emily; Nesbit, Stephanie; White, James; Parker, Ben; Jayne, David; Griffiths, Bridget; Isenberg, David A; Rahman, Anisur; Gordon, Caroline; D'Cruz, David P; Rhodes, Benjamin; Lanyon, Peter; Vital, Edward M; Yee, Chee-Seng; Edwards, Christopher J; Teh, Lee-Suan; Akil, M... Journal: Rheumatology Issue: Volume 57:Number 3(2018) Page Start: 470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lupus clinical trial eligibility in a real-world setting: results from the British Isles Lupus Assessment Group-Biologics Register (BILAG-BR). Issue 1 (23rd July 2021) Authors: Dyball, Sarah; Collinson, Sophie; Sutton, Emily; McCarthy, Eoghan M; Bruce, Ian N; Parker, Ben Journal: Lupus science & medicine Issue: Volume 8:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BRAF mutations are associated with increased iron regulatory protein‐2 expression in colorectal tumorigenesis. Issue 6 (2nd June 2017) Authors: Horniblow, Richard D.; Bedford, Matthew; Hollingworth, Robert; Evans, Sarah; Sutton, Emily; Lal, Neeraj; Beggs, Andrew; Iqbal, Tariq H.; Tselepis, Chris Journal: Cancer science Issue: Volume 108:Issue 6(2017) Page Start: 1135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. (18th April 2017) Authors: McCarthy, Eoghan M.; Sutton, Emily; Nesbit, Stephanie; Parker, Ben; Jayne, David; Griffiths, Bridget; Isenberg, David A.; Rahman, Anisur; Gordon, Caroline; D'Cruz, David P.; Rhodes, Benjamin; Lanyon, Peter; Vital, Edward M.; Yee, Chee-Seng; Edwards, Christopher J.; Teh, Lee-Suan; Akil, Mohammed; ... Journal: Rheumatology Issue: Volume 56:Number 6(2017) Page Start: 1041 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. (22nd May 2017) Authors: McCarthy, Eoghan M.; Sutton, Emily; Nesbit, Stephanie; Parker, Ben; Jayne, David; Griffiths, Bridget; Isenberg, David A.; Rahman, Anisur; Gordon, Caroline; D'Cruz, David P.; Rhodes, Benjamin; Lanyon, Peter; Vital, Edward M.; Yee, Chee-Seng; Edwards, Christopher J.; Teh, Lee-Suan; Akil, Mohammed; ... Journal: Rheumatology Issue: Volume 56:Number 6(2017) Page Start: 1049 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. O17 Effectiveness of rituximab in the treatment of neuro-psychiatric SLE: results from the British Isles Lupus Assessment Group Biologics Register. (26th April 2021) Authors: David, Trixy; Hum, Ryan Malcolm; Sutton, Emily; Parker, Benjamin; McCarthy, Eoghan; Bruce, Ian N Journal: Rheumatology Issue: Volume 60(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P166 Multimorbidity in SLE, a barrier to clinical trial eligibility: results from the BILAG-BR. (26th April 2021) Authors: Dyball, Sarah; Collinson, Sophie; Sutton, Emily; McCarthy, Eoghan; Parker, Ben; Bruce, Ian Journal: Rheumatology Issue: Volume 60(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study. (May 2023) Authors: Rodziewicz, Mia; Dyball, Sarah; Lunt, Mark; McDonald, Stephen; Sutton, Emily; Parker, Ben; Bruce, Ian N; Abernethy, Rikki; Ahmad, Yasmeen; Akil, Mohamed; Bartram, Sarah; Batley, Mike; Bharadwaj, Anurag; Bruce, Ian; Carlucci, Francesco; Chan, Antoni; Dasgupta, Bhaskar; D'Cruz, David; De Lord, Deni... Journal: Lancet Issue: Volume 5:Number 5(2023) Page Start: e284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry‐Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus. Issue 5 (22nd March 2023) Authors: Carter, Lucy M.; Alase, Adewonuola; Wigston, Zoe; Psarras, Antonios; Burska, Agata; Sutton, Emily; Yusof, Md Yuzaiful Md; Reynolds, John A.; McHugh, Neil; Emery, Paul; Wittmann, Miriam; Bruce, Ian N.; Vital, Edward M. Journal: Arthritis & rheumatology Issue: Volume 75:Issue 5(2023) Page Start: 697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗